Company Filing History:
Years Active: 2021-2025
Title: Patrick Langohr: Innovator in Pharmaceutical Treatments
Introduction
Patrick Langohr is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of severe community-acquired pneumonia. With a total of 3 patents to his name, Langohr's work is recognized for its innovative approach to addressing infectious diseases.
Latest Patents
One of Langohr's latest patents focuses on the treatment of severe community-acquired pneumonia. This invention provides a new therapeutic tool capable of treating infectious diseases. Specifically, it introduces a new pharmaceutical composition that comprises an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe community-acquired pneumonia (sCAP). This innovative approach aims to enhance the effectiveness of existing treatments and improve patient outcomes.
Career Highlights
Patrick Langohr is currently associated with Biotest AG, a company known for its commitment to developing innovative therapies. His work at Biotest AG has allowed him to explore new avenues in pharmaceutical research and development. Langohr's dedication to improving healthcare through innovation is evident in his patent contributions.
Collaborations
Langohr collaborates with esteemed colleagues such as Andrea Wartenberg-Demand and Ulrike Wippermann. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.
Conclusion
In summary, Patrick Langohr is a distinguished inventor whose work in pharmaceuticals has the potential to significantly impact the treatment of severe community-acquired pneumonia. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.